Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.

Safety Dermatological Evaluation: Genital Mucous Irritation - Test in Use - Dermacyd Femina Pocket BR (Lactic Acid).

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00794612

Enrollment

Registered

2008-11-20

Start date

2008-11-30

Completion date

Unknown

Last updated

2008-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.

Interventions

DRUGDermacyd Femina Pocket BR (Lactic Acid)

Dermacyd Femina Pocket BR (Lactic Acid) during 21 consecutive days

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Integral skin test in the region; * To use products of the same category;

Exclusion criteria

* Lactation or gestation; * Use of anti-inflammatory, anti-histaminic or immunosuppressant drugs; * Cutaneous disease (local or spread) in the evaluation area; * Pathology which may cause immunity depression, such as HIV, diabetes; * Endocrine pathology * Solar exposure 15 days before evaluation; * Treatment until four months before the selection. * Allergic or atopic history to cosmetics products The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Design outcomes

Primary

Measure	Time frame
Absence of irritation	From the start to the end of the study
Good acceptability	From the start to the end of the study

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026